Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings highlight that oxidative stress could activate T14 in the adult brain through AChE upregulation, contributing to neurodegeneration in Alzheimer’s disease.
LATEST NEWS
- Neuro-bio hosts the Tenants lunch for Culham Campus!
- Councillor Mark Lygo visits Neuro-Bio to meet with CEO & Founder Baroness Susan Greenfield
- Neuro-Bio attends the Global Mind Brain Health Summit at the University of Oxford
- Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference